European Heart Journal-Quality of Care and Clinical Outcomes

Papers
(The TQCC of European Heart Journal-Quality of Care and Clinical Outcomes is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology167
Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017151
Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017123
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs107
The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review107
Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic69
Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network59
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic50
Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality50
Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry47
Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown?46
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes43
Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation41
Cardiovascular comorbidities as predictors for severe COVID-19 infection or death41
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)39
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews35
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary34
Types of myocardial injury and mid-term outcomes in patients with COVID-1927
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease27
The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis25
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines25
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis24
Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation23
Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms22
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study21
A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999–201821
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation19
Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations18
Cumulative hospitalization deficit for cardiovascular disorders in Germany during the COVID-19 pandemic: insights from the German-wide Helios hospital network18
The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)16
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrilla16
A marker of systemic inflammation or direct cardiac injury: should cardiac troponin levels be monitored in COVID-19 patients?16
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions16
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines16
Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve15
Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study15
Temporal trends of mortality in patients with infective endocarditis: a nationwide study15
Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk15
Percutaneous vs. surgical revascularization for patients with unprotected left main stenosis: a meta-analysis of 5-year follow-up randomized controlled trials14
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re14
Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation14
Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysis14
Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outc14
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 201914
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)13
The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study13
Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry13
Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)13
Predicting the EQ-5D utilities from the Kansas City Cardiomyopathy Questionnaire in patients with heart failure13
Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study13
Does objectively measured light-intensity physical activity reduce the risk of cardiovascular mortality? A meta-analysis13
Sex differences in mortality and 90-day readmission rates after transcatheter aortic valve replacement: a nationwide analysis from the USA12
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?12
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–201912
Gender differences in complications following catheter ablation of atrial fibrillation12
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden12
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment11
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry11
Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000–2011
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction11
Poor quality of life in patients with and without frailty: co-prevalence and prognostic implications in patients undergoing percutaneous coronary interventions and cardiac catheterization11
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies11
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis11
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Progr11
High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study11
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term exten11
Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries10
Effect of coronary artery bypass grafting on quality of life: a meta-analysis of randomized trials10
Alerting trends in epidemiology for calcific aortic valve disease, 1990–2019: An age–period–cohort analysis for the Global Burden of Disease Study 201910
Patient-reported outcome measures in cardiovascular disease10
EURObservational Research Programme: a bibliometric assessment of its scientific output10
The burden of atherosclerosis in Portugal10
Shared decision-making: the patient on the forefront of care coordination10
Utilization of diagnostic resources and costs in patients with suspected cardiac chest pain10
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk10
Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry9
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom9
The association between cardiovascular disease admission rates and the coronavirus disease 2019 lockdown and reopening of a nation: a Danish nationwide cohort study9
Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials9
Treatment of older patients with atrial fibrillation by morbidity burden9
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials9
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice9
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis8
Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 20178
The influence of the 2020 COVID-19 pandemic on the implantation rates of cardiac implantable electronic devices in Germany: changes between 2020 Q1–Q3 and 2019 Q1–Q38
Evaluating the diagnostic and prognostic value of biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy8
Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry8
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)8
Will the COVID-19 epidemic reshape cardiology?7
Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection7
A tale of two countries: how decentralized organization and long-term investment build resilient healthcare systems7
Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I7
Time to benefit and harm of intensive blood pressure treatment: insights from SPRINT7
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study7
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland7
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry7
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study7
Door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty7
0.030497074127197